A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women.
Anastrozole has been studied across 21 research domains including 🔬 Oncology, 🧬 Hormones, ⏳ Longevity & Aging, 🦴 Bone & Joint, 💪 Strength & Power. The primary research focus is 🔬 Oncology with 75% of studies addressing this area.
The following compounds share molecular targets with Anastrozole, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Anastrozole is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.